Wed, Jun 26, 2024
A press release from the city-based drug maker said Dr Reddy's will acquire Haleon's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy ('NRT') category consists of Nicotinell, a global leader in the category with an extensive footprint in over 30 countries spanning Europe, Asia including Japan, and Latin America and local market-leading brand names of the product– Nicabate in Australia, Thrive in Canada, and Habitrol in New Zealand and Canada.
More >
Sun, May 19, 2024
The USFDA said the drug maker initiated the Class I recall in the US on April 8 this year.
Wed, Jan 31, 2024
The company's consolidated profit after tax (PAT) jumped by 11 per cent, while its revenue from operations was up by seven per cent Year-on-Year (YoY).
Mon, Jan 29, 2024
Zee Business research estimates the pharma firm to report a five per cent jump in its consolidated profit after tax (PAT) to Rs 1310 crore in the December quarter against Rs 1247 crore in the same quarter last fiscal.
Thu, May 11, 2023
Stocks to buy: Analysts have handpicked Dr Reddy's, Nazara Technologies, MATRIMONY.COM, Shyam Metalics and Mahanagar Gas to make the most of the current juncture on Dalal Street.
Tue, Apr 18, 2023
Which stocks to buy, hold or sell today? As Dalal Street enters the April 18 session, here's a look at what brokerages make of some of the key stocks that are in the focus. Stocks such as Larsen and Toubro, SBI Cards, Sun Pharma, Dr Reddy's Lab, Divi's Lab, ONGC, and other stocks are on their radar today.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
